News

Researchers at Utrecht University, Erasmus Medical Center and Harbour BioMed (HBM) today reported that they have identified a fully human monoclonal antibody that prevents the SARS-CoV-2 (COVID-19) virus from infecting cultured cells.

A study published in the journal Cell outlines a novel avenue for potentially treating COVID-19 – antibodies from a llama. The research is a collaborative effort from The University of Texas at Austin (UT Austin), the National Institutes of Health and Ghent University in Belgium

A group of researchers has developed a novel way to deliver molecules that target specific genes within cells. Their platform, which uses a modified form of diptheria toxin, has been shown to down-regulate critical genes in cancer cells, and could also be used for other genetic diseases.

A plant extract combination of fruits, leaves, and roots may help to relieve hangover symptoms, reveals research published online in BMJ Nutrition Prevention & Health.

Researchers have developed a new way to treat chronic pain, using a compound designed by themselves, tested in mice.

Childhood immunization with two common vaccines prevents tens of millions of episodes of antibiotic-treated illness each year, according to a new study.

A research team has gained a better understanding of the structures of nonribosomal peptide synthetases and the processes by which they work. This improved understanding could potentially allow bacteria and fungi to be leveraged for production of compounds.

A landmark partnership has been announced today between the University of Oxford and the biopharmaceutical company AstraZeneca. The partnership will facilitate the further development and large-scale manufacturing of the COVID-19 vaccine candidate, ChAdOx1 nCoV-19, currently in clinical trials.

A team of scientists has created cytokine-secreting “backpacks” for macrophages that keep them in their tumor-killing state for up to five days after they arrive at a tumor site. They have also been found to slow tumor growth and reduce metastasis in mice with an aggressive form of breast cancer.

An anti-inflammatory drug developed 25 years ago is now being tested as a way to prevent acute respiratory distress in patients with COVID-19.